Tracon Pharmaceuticals, Inc.
TCONDelisted Jul 19, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001394319
Tracon Pharmaceuticals, Inc. was delisted on Jul 19, 2024; its insiders filed their last Form 4 on Mar 13, 2024; 29 institutions reported holding it in 13F filings for Q1 2024, worth $1.39M in total; no superinvestor held it.
Q1 2024 vs. Q4 2023
How the institutions holding Tracon Pharmaceuticals, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 24 | 29 | +5 |
| Shares | 5.16M | 3.25M | −1.92M (−37.2%) |
| Value | $903.4K | $1.39M | +$487.3K (+53.9%) |
New holders (11)
Institutions that held Tracon Pharmaceuticals, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| LPL Financial LLC | 450,650 | $193.7K | 0.00% |
| Jane Street Group, LLC | 182,307 | $78.4K | 0.00% |
| UBS Group AG | 91,333 | $39.3K | 0.00% |
| Susquehanna International Group, LLP | 77,868 | $33.5K | 0.00% |
| HRT Financial LP | 54,364 | $23.0K | 0.00% |
| Two Sigma Investments, LP | 34,822 | $15.0K | 0.00% |
| XTX Topco Ltd | 27,965 | $12.0K | 0.00% |
| ETF Portfolio Partners, Inc. | 24,641 | $10.6K | 0.00% |
| SpiderRock Advisors, LLC | 22,983 | $8.30K | 0.00% |
| Jump Financial, LLC | 10,500 | $4.51K | 0.00% |
| Mercer Global Advisors Inc | 10,000 | $4.00K | 0.00% |
Sold out (6)
Institutions that held Tracon Pharmaceuticals, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Ikarian Capital, LLC | 2,765,530 | $484.2K |
| Boothbay Fund Management, LLC | 258,844 | $45.3K |
| GTS Securities LLC | 15,794 | $2.76K |
| Qube Research & Technologies Ltd | 800 | $140 |
| Morgan Stanley | 200 | $35 |
| Cutler Group LP | 1,200 | $0 |